Page 45 - MemoriaER-Eng

www.ciberer.es

Participation in forums and events enabling collaboration with the

private sector

Finally, in 2013 the Management Office staff and the CIBERER Management at-
tended and participated in other forums and events of particular interest enabling

some type of collaboration with the private sector, such as:

• TRANSFIERE which took place on February 13-14, 2013 in Malaga. CIBERER

was represented by Dr. Juan Luque, CIBERER Scientific Manager.

• 6th International Conference on Orphan Drugs, which took place on Fe-
bruary 14-16, 2013 in Seville. Dr. Merche Serrano as well as managers Mónica

Bescos and Juan Luque, were invited to attend said event to explain the acti-

vity that CIBERER is performing.

• “Symposium biobanks and biomedical collections an ethical fra- í
mework for future research”, which took place on June 19-20, 2012 in

Strasbourg, France. Dr. Palau, CIBERER Scientific Director, attended this

event organized by the European Council on behalf of CIBERER.
ó

• Annual Meeting of the European Society of Human Genetics (ESHg),
which took place on June 23-26, 2012 in Nuremberg, Germany. A number of

CIBERER investigators participated in the meeting, included Dr. Palau.
é

• V Spanish Drug Discovery Network Meeting, which took place in the

Science Park of the Universidad de Valencia, October 24-25, 2013. Dr. Juan
Luque, CIBERER Scientific Manager, was present at this event.
í

Furthermore, CIBERER has co-organized and participated in several conference

and workshops in collaboration with companies to deal with different aspects rela-
í
ting to the etiology, causes, clinical symptoms and treatment of RD:

• Da Mundial de las Enfermedades Raras “Investigar es avanzar” in the
CECA, Madrid. Several companies and institutions representing the private

sector attended.

• 8th International Meeting on Translational Research and Persona-

lized Medicine: Genomic Medicine in hospitals in the 21st Century,
Fundacin Jimnez Daz de Madrid with the collaboration of Roche Institute.

• DNA-Day CIBERER Workshop at Hospital Universitario La Paz de Madrid

with the collaboration of Roche, Genicell Biotech, Sistemas Genómicos, Agi-

lent Technologies, Abyntek, Progenika and Perkin Elmer.

• 27th National Conference of the Spanish Association of Human Gene- 13
tics. A number of research groups from CIBERER and from the field of rare 20
T
diseases were represented at this event.
OR
P
• 3rd Conference of the Group for Rare Diseases in Adults. This confe- RE
L
rence was held at Hospital Clnic de Barcelona and Genzyme and Actelion A
collaborated in it.
NU
N
• A
12th International Congress of Inborn Errors of Metabolism (ICIEM R /
2013). CIBERER collaborated in this international event in which 20 compa- E
ER
nies from the pharmaceutical and biotech sectors participated.
B
CI
•
Conference on pharmacological chaperones in lysosomal diseases

and other applications. Held at the Biomedical Research Centre of Aragon 45
(CIBA) C Zaragoza with the participation of Alexion.